A Patient With BRAF V600E Lung Adenocarcinoma Responding to Vemurafenib
- 1 October 2012
- journal article
- case report
- Published by Elsevier BV in Journal of Thoracic Oncology
- Vol. 7 (10), e23-e24
- https://doi.org/10.1097/jto.0b013e3182629903
Abstract
No abstract availableThis publication has 4 references indexed in Scilit:
- Survival in BRAF V600–Mutant Advanced Melanoma Treated with VemurafenibNew England Journal of Medicine, 2012
- Clinical Features and Outcome of Patients With Non–Small-Cell Lung Cancer Harboring BRAF MutationsJournal of Clinical Oncology, 2011
- Improved Survival with Vemurafenib in Melanoma with BRAF V600E MutationNew England Journal of Medicine, 2011
- Genetic Predictors of MEK Dependence in Non–Small Cell Lung CancerCancer Research, 2008